Effect of Lowering the Glycemic Load With Canola Oil on Glycemic Control and Cardiovascular Risk Factors: A Randomized Controlled Trial Featured Article:

Slides:



Advertisements
Similar presentations
Effect of a dietary Portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia Erin Woodard.
Advertisements

Reductions in Regimen Distress Are Associated With Improved Management and Glycemic Control Over Time Featured Article: Danielle Hessler, Lawrence Fisher,
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Foos et al, EASD, Lisbon, 13 September 2011 Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta- analysis studies Volker.
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): Urinary Screening and Baseline Biochemical and Cardiovascular Assessments Featured.
Resistant hypertension increases patients’ cardiovascular risk 30% of all treated patients develop resistant hypertension [1-5]. Resistant hypertension.
Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a.
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
Fructose & Diabetes Go to to download these slides for your presentations.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized.
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia.
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial Featured Article: Ravi Retnakaran, Caroline K.
Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections.
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Simvastatin Increases HDL-C and Apolipoprotein A-1 Levels Significantly More Than Atorvastatin John P. Kastelein, Evan A. Stein, Michael A. Davidson, John.
OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Ramón Estruch, M.D., Ph.D., …and 18 others for PREDIMED study investigators Published:
Spinal Cord Stimulation and Pain Relief in Painful Diabetic Peripheral Neuropathy: A Prospective Two-Center Randomized Controlled Trial Featured Article:
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients Daan Kromhout, MPH PhD for the Alpha Omega Trial Group.
Glycemic Control in Simultaneous Islet-Kidney Versus Pancreas-Kidney Transplantation in Type 1 Diabetes: A Prospective 13-Year Follow-up Featured Article:
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
 2010 Wellsource, Inc. All rights reserved. Polyunsaturated Fats and CHD Harvard Study 2010.
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension Featured Article: Ilkka Tikkanen, Kirsi Narko, Cordula Zeller, Alexandra.
Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal Overgrowth.
Methodological Issues in Systematic Review - Formulating Questions - Joseph Lau, MD Tufts Medical Center EPC AHRQ Annual Meeting September 10, 2008.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea A.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.
Extra-Virgin Olive Oil Reduces Glycemic Response to a High–Glycemic Index Meal in Patients With Type 1 Diabetes: A Randomized Controlled Trial Featured.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of non-pharmaceutical interventions in primary.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
The FAVORIT Study (Folic Acid for Vascular Outcome Reduction in Transplantation) Source Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering.
Baseline characteristics of HPS participants by prior cerebrovascular disease.
What should the Systolic BP treatment goal be in patients with CKD?
The SPRINT Research Group
Neal B, et al. Diabetes Care 2015;38:403–411
by Sarah Steinmetz and Amber Brouillette
Canagliflozin: Real World Experience
on behalf of the LEADER Trial Steering Committee and Investigators
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
EMPA-REG OUTCOME Trial design: Patients with type 2 diabetes mellitus (DM2) at high risk for CV events were randomized to receive in a 1:1:1 fashion either.
The Hypertension in the Very Elderly Trial (HYVET)
The differences in sedentary behaviour and physical activity levels between the CVD groups*. The differences in sedentary behaviour and physical activity.
The Diabetes Cross-Disciplinary Index (DXDI).
Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion  Matthew.
The excess effect of 3 or 6 months low to moderate carbohydrate diet compared with high-carbohydrate diet on HbA1c (%) versus reported intake (Energy %)
Changes In Nutrient Intake And Dietary Quality Among Participants With Type 2 Diabetes Following A Low-fat Vegan Diet Or A Conventional Diabetes Diet For.
Relevant Biomarkers of Inflammation and Their Possible Role in Atherosclerosis Arpita Basu, et al. ATVB, 2006; 26;
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
David J.A. Jenkins et al. JACC 2018;71:
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Saxagliptin improves glycemic control in younger and older individuals with type 2 diabetes. Saxagliptin improves glycemic control in younger and older.
Forest plot of randomised controlled trials investigating the effects of pasta in the context of low-GI dietary patterns on body weight (kg). n=2448. Forest.
Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review by Hugh Gallagher, Simon.
HR for mortality in ischemic heart disease.
Presentation transcript:

Effect of Lowering the Glycemic Load With Canola Oil on Glycemic Control and Cardiovascular Risk Factors: A Randomized Controlled Trial Featured Article: David J.A. Jenkins, Cyril W.C. Kendall, Vladimir Vuksan, Dorothea Faulkner, Livia S.A. Augustin, Sandra Mitchell, Christopher Ireland, Korbua Srichaikul, Arash Mirrahimi, Laura Chiavaroli, Sonia Blanco Mejia, Stephanie Nishi, Sandhya Sahye- Pudaruth, Darshna Patel, Balachandran Bashyam, Edward Vidgen, Russell J. de Souza, John L. Sievenpiper, Judy Coveney, Robert G. Josse, and Lawrence A. Leiter Diabetes Care Volume 37: July, 2014

STUDY OBJECTIVE To determine the combined effect of  -linolenic acid (ALA), monounsaturated fatty acid (MUFA), and low glycemic load (GL) on glycemic control and cardiovascular disease (CVD) risk factors in type 2 diabetes Jenkins D.J.A. et al. Diabetes Care 2014;37:

STUDY DESIGN AND METHODS Study was a parallel design, randomized trial wherein each 3-month treatment was conducted in a Canadian academic center between March 2011 and September 2012 Involved 141 participants with type 2 diabetes treated with oral antihyperglycemic agents Jenkins D.J.A. et al. Diabetes Care 2014;37:

STUDY DESIGN AND METHODS Participants were provided with dietary advice on either a low-GL diet with ALA and MUFA given as a canola oil– enriched bread supplement (test) or a whole-grain diet with a whole-wheat bread supplement (control) Primary outcome was HbA1c change Secondary outcomes included calculated Framingham CVD risk score and reactive hyperemia index (RHI) ratio Jenkins D.J.A. et al. Diabetes Care 2014;37:

RESULTS 79% of the test group and 90% of the control group completed the trial The test diet reduction in HbA1c units of 20.47% was greater than that for the control diet (20.31%) The greatest benefit was observed in individuals with higher systolic blood pressure (SBP) Greater reductions were seen in CVD risk score for the test diet, whereas the RHI ratio increased for the control diet Jenkins D.J.A. et al. Diabetes Care 2014;37:

CONCLUSIONS A canola oil–enriched low-GL diet improved glycemic control in type 2 diabetes, particularly in participants with raised SBP, whereas whole grains improved vascular reactivity Jenkins D.J.A. et al. Diabetes Care 2014;37: